Building Cognitive Resilience to Vaccine Misinformation Using AI in Europe

ConditionHealthy
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20+
SponsorLondon School of Hygiene and Tropical Medicine

About this trial

This multi-country trial evaluates an AI chatbot designed to counter cognitive biases and inoculate parents against vaccine misinformation, embedded within a large survey across five European countries (n=5,000). Scaled from a 2026 single-country study, outcomes compare behavioural and attitudinal responses against standard-of-care materials (e.g., UNICEF infographics) to identify effective, scalable misinformation interventions.

Eligibility criteria

Qualifiers

Parents or caregivers with children under 18 years old in the five target countries (UK, Netherlands, Croatia, Latvia, and Slovakia); and

Those who have regular access to a digital device and the internet

Disqualifiers

Participants who do not meet the inclusion criteria.

Trial design

Treatments tested in this trial

  • AI-driven chatbot
  • Social media infographic

Treatment groups

5,000 Participants
are divided into 2 treatment groups

Locations

This trial has no locations